Berberine as Adjuvant Treatment for Schizophrenia Patients
This summary needs review. Please check the official study record and contact the research team for details.
In Tuenmen
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
In TuenmenThis summary needs review. Please check the official study record and contact the research team for details.
In TianjinThis study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.
Location not clearly listedThis study is looking at care and outcomes for people with Schizophrenia Therapeutics. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
In TianjinThis study is comparing Berberine with placebo for people with Schizophrenia or Negative Symptoms of Schizophrenia. Participants receive Berberine or placebo and complete study visits and assessments.
In TianjinThis summary needs review. Please check the official study record and contact the research team for details.
In TianjinThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including InnsbruckThis study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
In BerlinThis summary needs review. Please check the official study record and contact the research team for details.
In BernThis summary needs review. Please check the official study record and contact the research team for details.
In RoslindaleThis study was terminated in the United States. It is testing Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone for schizophrenia.
In KetteringThis summary needs review. Please check the official study record and contact the research team for details.
In Le Kremlin-BicêtreHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.